Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study

INTRODUCTION: The aim of this study was to examine whether circulating levels of the proinflammatory glycoprotein tenascin-C (TNC) are useful as an activity-specific or predictive biomarker in systemic lupus erythematosus (SLE). METHODS: Serum TNC levels were determined by enzyme-linked immunosorben...

Descripción completa

Detalles Bibliográficos
Autores principales: Závada, Jakub, Uher, Michal, Svobodová, Radka, Olejárová, Marta, Hušáková, Markéta, Ciferská, Hana, Hulejová, Hana, Tomčík, Michal, Šenolt, Ladislav, Vencovský, Jiří
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660660/
https://www.ncbi.nlm.nih.gov/pubmed/26608564
http://dx.doi.org/10.1186/s13075-015-0862-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660660/
https://www.ncbi.nlm.nih.gov/pubmed/26608564
http://dx.doi.org/10.1186/s13075-015-0862-4

Ejemplares similares